IceCure Medical Ltd. (ICCM)

Name: IceCure Medical Ltd. (ICCM) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: IceCure Medical Ltd. (ICCM)

Stock Card

$2.24

$-0.02 (-0.88%)

As on 03-Sep-2026 10:37EDT

Market cap

$8 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

P/B Ratio

0.7

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

IceCure Medical (ICCM) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.24 High: 2.27

52 Week Range

Low: 2.12 High: 42.00

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-2.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-2.6
Debt to Equity

0
Book Value

$--
EPS

$-6.7
Face value

--
Shares outstanding

3,426,715

10 Years Aggregate

CFO

$-60.44 Mln

EBITDA

$-66.94 Mln

Net Profit

$-69.62 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
IceCure Medical (ICCM)	-87.8	-22.5	-46.3	-93.1	-58.9	-62.4	--
BSE Sensex	-10.1	-2.5	2.0	-5.0	5.2	5.7	10.3
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 03-Sep-2026 | #As on 26-Oct-2023

Company	2025	2023	2022	2021
IceCure Medical (ICCM)	-43.5	-31.0	-49.2	1,119.0
S&P Small-Cap 600	4.0	13.9	-17.4	25.3
BSE Sensex	9.1	18.7	4.4	22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
IceCure Medical (ICCM)	2.2	7.9	4.0	-16.9	-423.7	-161.2	--	0.7
InMode (INMD)	14.8	854.5	374.6	77.5	22.3	11.8	12.3	1.4

Shareholding Pattern

View Details

About IceCure Medical (ICCM)

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and... internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel. Read more

CEO & Director

Mr. Eyal Shamir
CEO & Director

Mr. Eyal Shamir
Headquarters

Caesarea
Website

https://www.icecure-medical.com

FAQs for IceCure Medical (ICCM)

What is the current share price of IceCure Medical Ltd (ICCM) Today?

The share price of IceCure Medical Ltd (ICCM) is $2.24 (NASDAQ) as of 03-Sep-2026 10:37 EDT. IceCure Medical Ltd (ICCM) has given a return of -58.95% in the last 3 years.

What is the current PB & PE ratio of IceCure Medical Ltd (ICCM)?

Since, TTM earnings of IceCure Medical Ltd (ICCM) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.10	0.16
2024	-0.13	0.30
2023	-3.34	4.02
2022	-0.11	0.08
2021	-11.03	4.05

What is the 52 Week High and Low of IceCure Medical Ltd (ICCM)?

The 52-week high and low of IceCure Medical Ltd (ICCM) are Rs 42.00 and Rs 2.12 as of 03-Sep-2026.

What is the market cap of IceCure Medical Ltd (ICCM)?

IceCure Medical Ltd (ICCM) has a market capitalisation of $ 8 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in IceCure Medical Ltd (ICCM)?

Before investing in IceCure Medical Ltd (ICCM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.